Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,220.0
-0.1 (-0.00%)

 

  • STI Straits Times Index
    3,220.0
    -0.1 (-0.00%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,544.5
    5.3 (0.34%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    27,815.6
    85.6 (0.31%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,917.0
    10.9 (0.38%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    23,687.6
    -140.1 (-0.59%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    5,866.9
    -5.0 (-0.09%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,069.2M
  • Value: 1,202.2M
  • Rise: 166
  • Fall: 130
  • Unch: 518

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
AusGroup^0.042+0.003
Singtel3.220-0.060
Dyna-Mac0.144+0.013
Medtecs Intl0.113-0.002
GSS Energy0.104+0.006
Interra Resource^0.073+0.006
Mermaid Maritime0.110+0.010
Mapletree Log Tr1.980-0.010
MarcoPolo Marine0.022+0.001
BlackGoldNatural0.019+0.001

World Indices

World Indices
Name Last Change
Nasdaq 9,731.2 +19.2
HSI 27,815.6 +85.6
HSCEI 10,863.5 +28.1
Jakarta 5,866.9 -5.0
Nikkei 225 23,687.6 -140.1
SSE Comp 2,917.0 +10.9
Shanghai A 3,056.8 +11.5
Shanghai B 235.1 -0.1
KOSPI 2,243.6 +10.6

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

LUMINEX CORP(DEL) LUMINEX CORP
Updated on 14 Feb 2020 (End of trading day)
Last (USD): 23.720 Change: -0.310 High: 24.080 Remarks: -
Change (%): -1.29 Low: 23.570
Open 24.050 Yesterday's Close 24.029999999999998
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 245,300 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a 0.40389 Trailing EPS (USD) e -0.08643 NAV (USD) b 10.3183
PE a 58.729 Trailing PE f - Price / NAV b 2.2988
Dividend (USD) d 0.233859 Cash In Hand (USD) g 1.3134 Issued & Paid-up Shares c 45,052,000
Dividend Yield (%) d 0.986 Price / Cash In Hand g 18.060 Treasury Shares h -
Beta - 75 Daysi 1.161 R-Squared - 75 Days(%)i 8.11 Market Cap (M) 1,068.633
Beta - 500 Daysi 0.042 R-Squared - 500 Days (%)i 0.03 Enterprise Value (M) 1,026.642
Piotroski F Score 4 Exchange Code LMNX Par Value ( $ ) n.a.
52 Weeks Volatility (%) 31.75 Free Float (%) 92.3
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 07 Nov 2019.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 13 Jul 2015.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference LUMINEX CORP(DEL) NASDAQ 1,068.633 58.729 - 2.2988 0.986
Industry Biotechnology NASDAQ 2,474.612 252.858 218.256 5.9665 0.733
Local Peer AMGEN INC NASDAQ 131,810.068 15.703 16.808 13.6266 2.522
Local Peer GILEAD SCIENCES INC NASDAQ 85,530.960 15.679 15.880 3.7762 3.417
Local Peer VERTEX PHARMACEUTICAL NASDAQ 63,214.968 30.154 53.717 10.3882 -
Local Peer BIOGEN INC NASDAQ 57,963.312 13.082 9.843 4.3440 -
Local Peer REGENERON PHARMACEUTICALS INC NASDAQ 43,958.479 17.983 20.776 3.9639 -
Local Peer ILLUMINA INC NASDAQ 43,941.240 53.198 43.854 9.5255 -
Local Peer ALEXION PHARMACEUTICAL INC NASDAQ 22,706.887 292.611 9.444 2.0145 -
Local Peer SEATTLE GENETICS INC NASDAQ 20,338.738 - - 10.8399 -
Local Peer INCYTE CORPORATION NASDAQ 17,006.077 155.316 38.053 6.5448 -
Local Peer GALAPAGOS NV SPON ADR REPR 1 ORD SHS NASDAQ 16,748.106 - 53.964 6.0595 -
Local Peer BIOMARIN PHARMACEUTICAL NASDAQ 15,988.421 - - 5.2005 -
Local Peer ALNYLAM PHARMACEUTICALS INC NASDAQ 14,489.561 - - 10.0714 -
Other Local Peers EXACT SCIENCES CORP (NASDAQ), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), 10X GENOMICS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), MODERNA INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), EXELIXIS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), BLUEBIRD BIO INC (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), NEKTAR THERAPEUTICS (NASDAQ), FIBROGEN INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), IMMUNOMEDICS INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), ALKERMES PLC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), INSMED INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), UNIQURE N.V. (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), ALECTOR INC (NASDAQ), EPIZYME INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), XENCOR INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), REGENXBIO INC (NASDAQ), ARVINAS INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), CORTEXYME INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), VIELA BIO INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), VERACYTE INC (NASDAQ), NEXTCURE INC (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), IMMUNOGEN INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), AVITA MEDICAL LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), DERMIRA INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), CYTOKINETICS INC (NASDAQ), AVROBIO INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), RETROPHIN INC (NASDAQ), OMEROS CORP (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), PRECIGEN INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), XBIOTECH INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), NANTKWEST INC (NASDAQ), ARDELYX INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), COMPUGEN (NASDAQ), KURA ONCOLOGY INC (NASDAQ), MERUS B V (NASDAQ), PROTHENA CORP PLC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), AGENUS INC (NASDAQ), MACROGENICS INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), RECRO PHARMA INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), PDL BIOPHARMA INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), PROGENICS PHARMACEUTICALS INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), AVID BIOSERVICES INC (NASDAQ), CABALETTA BIO INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), STEMLINE THERAPEUTICS INC (NASDAQ), NEUROINSIGHTS NEUROTECH (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), PERSONALIS INC (NASDAQ), IVERIC BIO INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), VBI VACCINES INC CDA (NASDAQ), ADURO BIOTECH INC (NASDAQ), MEDICINOVA INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), KAMADA (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), GERON CORP (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), NOVAVAX INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), XOMA CORP (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), IMV INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), ATHERSYS INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), AFFIMED N V (NASDAQ), CHIASMA INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), VERASTEM INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), CONTRAFECT CORP (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), CELYAD ADS EACH REPR 1 ORD (NASDAQ), ARAVIVE INC (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), OTONOMY INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), CHIMERIX INC (NASDAQ), SAVARA INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), VACCINEX INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), SESEN BIO INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), ORGENESIS INC (NASDAQ), INFLARX N V (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), EQUILLIUM INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), VERMILLION INC (NASDAQ), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), COHBAR INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), SYNLOGIC INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), TREVENA INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), ADVAXIS INC (NASDAQ), NEWLINK GENETICS CORP (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), SOLIGENIX INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), INMUNE BIO INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), VAXART INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), RESTORBIO INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), ZAFGEN INC (NASDAQ), CURIS INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), NEON THERAPEUTICS INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), EVOGENE LTD (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), ATYR PHARMA INC (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), INNOVATE BIOPHARMACEUTICALS INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), OCUGEN INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), BIOCARDIA INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), SOPHIRIS BIO INC (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), CORREVIO PHARMA CORP (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), CONATUS PHARMACEUTICALS INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 20 ORD SHS(R/S) (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), PRECIPIO INC (NASDAQ), CYCLACEL PHARMA IN (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), TOCAGEN INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), BENITEC BIOPHARMA LTD SPON ADS EA REPR 200 ORD SHS(POST SPLIT) (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), SENESTECH INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), SPHERIX INC (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), THERAPIX BIOSCIENCES LTD SPON ADR EACH REP 40 ORD (POST SPLIT) (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ)
Global Peer CSL ASX 150,321.180 56.029 51.892 - 0.801
Global Peer AMGEN-T HKEx 589,807.000 8.965 9.598 7.8255 4.417
Global Peer AGILENT TECHNOLOGIES INC NYSE 26,670.110 84.399 24.902 5.6171 0.711
Global Peer WUXI BIO HKEx 150,444.488 201.422 157.467 15.4864 -
Global Peer SINO BIOPHARM HKEx 147,606.486 13.776 14.297 4.3959 0.623
Global Peer BEIGENE HKEx 100,417.317 - - 10.0192 -
Global Peer GENSCRIPT BIO HKEx 33,693.886 202.626 - 9.5016 -
Global Peer Lonza SGX 5,937.453 6.613 6.613 0.6568 4.787
Global Peer 3SBIO HKEx 27,330.077 18.066 21.990 2.6937 -
Global Peer EMERGENT BIOSOLUTIONS INC NYSE 3,261.088 52.011 758.393 3.1508 -
Other Global Peers ALPHAMAB-B (HKEx), HAOHAI BIOTEC (HKEx), POLYNOVO LIMITED (ASX), FRONTAGE (HKEx), AVITA MEDICAL LTD (ASX), MYOVANT SCIENCES LTD (NYSE), MESOBLAST LTD (ASX), VIVA BIOTECH (HKEx), KADMON HLDGS INC (NYSE), ASCENTAGE-B (HKEx), ASCLETIS-B (HKEx), ARCUS BIOSCIENCES INC (NYSE), SINOMAB BIO-B (HKEx), NANOVIRICIDES INC (NYSE American), ESSEX BIO-TECH (HKEx), LEE'S PHARM (HKEx), PFENEX INC (NYSE American), TELIX PHARMACEUTIC (ASX), DPHARMA (Bursa), NEXT SCIENCE LTD (ASX), BBI LIFE SCI (HKEx), LINEAGE CELL THERAPEUTICS INC (NYSE American), NEUREN PHARMACEUTICALS LTD (ASX), CEL-SCI CORP (NYSE American), UNI-BIO GROUP (HKEx), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), 22ND CENTURY GROUP INC (NYSE American), ENZO BIOCHEM INC (NYSE), IMMUTEP LTD (ASX), IMUGENE LIMITED (ASX), PALATIN TECHNOLOGIES INC (NYSE American), CYNATA THERAPEUTICS LTD (ASX), SYNTHETIC BIOLOGICS INC (NYSE American), BIOTRON (ASX), CT ENTERPRISE (HKEx), ARMATA PHARMACEUTICALS INC (NYSE American), INVEX THERAPEUTICS LTD NPV (ASX), BIOSINO BIO-TEC (HKEx), IBIO INC (NYSE American), MEMPHASYS LTD (ASX), CCP TECHNOLOGIES LTD (ASX), ANTEOTECH LIMITED (ASX), REGENT PACIFIC (HKEx), KAZIA THERAPEUTICS LIMITED (ASX), GENETIC TECHNOLOGIES (ASX), ORAGENICS INC (NYSE American), BIONOMICS LTD (ASX), ACTINOGEN MEDICAL LTD (ASX), ACTINIUM PHARMACEUTICALS INC (NYSE American), RHINOMED LIMITED (ASX), INDIA GLOBALIZATION CAPITAL INC (NYSE American), PRESCIENT THERAPEUTICS LIMITED (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), Suntar Eco-City^ (SGX), PATRYS LIMITED (ASX), REGENEUS LTD (ASX), ALTERITY THERAPEUTICS LIMITED (ASX), ADALTA LTD (ASX), SIENNA CANCER DIAGNOSTICS LTD (ASX), HAO WEN HLDGS (HKEx), AIM IMMUNOTECH INC (NYSE American), ANATARA LIFESCIENCES LTD (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), BENITEC BIOPHARMA LTD (ASX), NOVABAY PHARMACEUTICALS INC (NYSE American), LIVING CELL TECHNOLOGIES (ASX), AUSTRALIAN PRIMARY HEMP LTD (ASX), LEAF RESOURCES LTD (ASX), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), AMPLIA THERAPEUTICS LTD (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), NANOLLOSE LTD (ASX), FACTOR THERAPEUTICS LIMITED (ASX), CRYOSITE (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+0.170
+0.72 %
10 Days -+1.035
+4.56 %
20 Days -+0.540
+2.33 %
Medium Term Return 3 Months 0.090+3.560
+18.11 %
6 Months 0.180+3.090
+15.85 %
1 Year 0.300-2.320
-7.76 %
Long Term Return 2 Years 0.480+4.000
+22.72 %
3 Years 0.720+5.470
+33.92 %
5 Years 0.720+7.920
+54.68 %
Annualised Return Annualised --
+9.12 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 17.345 - 26.815 Change From 1 Year Low +6.375 % Change From 1 Year Low (%) +36.75
Change From 1 Year High -3.095 % Change From 1 Year High (%) -11.54
2 Years Range 17.345 - 35.370 Change From 2 Years Low +6.375 % Change From 2 Years Low (%) +36.75
Change From 2 Years High -11.650 % Change From 2 Years High (%) -32.94
5 Years Range 15.410 - 35.370 Change From 5 Years Low +8.310 % Change From 5 Years Low (%) +53.93
Change From 5 Years High -11.650 % Change From 5 Years High (%) -32.94
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Luminex Corp. develops, manufactures and markets proprietary biological testing technologies and products with applications throughout the life sciences and diagnostics industries. The company was founded by Mark B. Chandler and Van S. Chandler in May 1995 and is headquartered in Austin, TX.

Historical Price Data

Date Open High Low Close Volume VWAP
14 Feb 2020 24.050 24.080 23.570 23.720 245,300 -
13 Feb 2020 24.520 24.720 23.990 24.030 219,698 -
12 Feb 2020 24.430 24.920 23.930 24.640 410,889 -
11 Feb 2020 24.000 25.790 23.560 24.265 1,046,882 -
10 Feb 2020 23.520 23.710 23.000 23.670 299,966 -
07 Feb 2020 24.170 24.330 23.540 23.550 507,202 -
06 Feb 2020 24.010 24.555 23.790 24.260 681,298 -
05 Feb 2020 23.750 24.120 23.620 23.970 250,634 -
04 Feb 2020 23.500 23.680 23.275 23.540 389,787 -
03 Feb 2020 22.960 23.270 22.860 23.270 338,764 -
31 Jan 2020 23.110 23.170 22.370 22.685 218,325 -
30 Jan 2020 22.990 23.180 22.905 23.160 121,979 -
29 Jan 2020 23.160 23.350 23.090 23.180 174,405 -
28 Jan 2020 22.960 23.210 22.800 23.160 111,818 -
27 Jan 2020 22.160 22.840 22.160 22.800 139,460 -
24 Jan 2020 22.540 22.620 22.230 22.510 207,082 -
23 Jan 2020 22.590 22.670 22.260 22.535 343,066 -
22 Jan 2020 23.140 23.280 22.550 22.590 309,832 -
21 Jan 2020 23.080 23.250 22.980 23.125 254,452 -
17 Jan 2020 23.880 23.880 22.970 23.180 273,706 -
16 Jan 2020 23.690 23.800 23.375 23.720 146,381 -
15 Jan 2020 23.420 23.845 23.340 23.500 548,765 -
Summary
Current 2 Weeks
(03 Feb 2020 to 14 Feb 2020)
22.960 25.790 22.860 23.720 4,390,420 -
Previous 2 Weeks
(17 Jan 2020 to 31 Jan 2020)
23.880 25.790 22.860 22.685 2,154,125 -
4 Weeks from
(18 Dec 2019 to 16 Jan 2020)
21.780 25.790 21.670 23.720 6,379,996 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.